The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Unlocking Real-World Data to Improve Outcomes
Sujay Jadhav, CEO of Verana Health, discusses the potential for real-world data to improve outcomes for patients, how Verana is addressing challenges these data can present, and the areas of medicine on which it is focused.
A Silicon Valley Entrepreneur Investing at the Intersection of Tech and Biotech
Swaroop “Kittu” Kolluri, founder and managing director Neotribe Ventures, discusses the state of AI, the ability of technology to transform the healthcare environment, and Neotribe’s approach to investing.
A Company Betting Its Physics-Based AI Will Fuel a Quantum Leap in Drug Discovery
Tom Miller, co-founder and CEO of Iambic Therapeutics, discusses the company’s AI platform, the insights Iambic gains from using a quantum mechanics-based approach to drug discovery, and its growing pipeline of cancer therapies.
Detecting Alzheimer’s Disease Early through a Blood Test
John McDonough, executive chair and CEO of Sunbird Bio, discusses the company’s diagnostic test in development for Alzheimer’s disease, how it has the potential to impact treatments and outcomes for millions of patients with the condition, and how its merger with Glympse Bio is expected to push it into new markets.
Addressing Supply-Chain Challenges Underlying Drug Shortages with Synthetic Biology
Christina Smolke, co-founder and CEO of Antheia, about the supply-chain challenges underlying drug shortages, how the company is using synthetic biology to create a reliable supply of active pharmaceutical ingredients, and its growing pipeline of products in development.
Building Better and More Affordable Vaccines
Thomas Rademacher, co-founder and CEO of Emergex Vaccines, discusses the company’s platform technologies, the manufacturing advantages they offer, and its pursuit of universal coronavirus and influenza vaccines that work across variants.
The content is interesting and it’s one of the podcasts I listen to most, but the advertisement and especially the jazz transition music is SO LOUD. When I’m driving and my hands are occupied, I actively cringe at the expectation of having my eardrums blasted when an episode begins or ends. When I’m not driving I try to skip ahead to the ~2 minute mark, because missing a bit of starting context from the actual show is worth preserving my hearing. Please make the audio levels consistent.
I am a longtime investor in Biotech and find the topics and interviews extremely interesting. The sound is not that good but it really doesn’t matter when the content is interesting. I would shorten the intro jingle by 50%. Keep up the good work.
Not for physicians
I’m a physician doing translational research in gene therapy. At least for the medical part the interviews discuss inaccurate information. For example there’s a talk where the interviewee says that in medicine therapy for most or all diseases are only symptom based “...such as diabetes and cancer...” which is absolutely wrong as especially in these diseases therapy starts as early as possible specifically to prevent symptoms. In addition there are some interviews where it seems that the members of the discussion haven’t discussed before hand what points will be touched and sometimes the interviewee “corrects the interviewer” which makes listening confusing. I’m unsubscribing and will search for other translational gene therapy research podcasts.